BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32173514)

  • 1. The cytokine network in the pathogenesis of major depressive disorder. Close to translation?
    Petralia MC; Mazzon E; Fagone P; Basile MS; Lenzo V; Quattropani MC; Di Nuovo S; Bendtzen K; Nicoletti F
    Autoimmun Rev; 2020 May; 19(5):102504. PubMed ID: 32173514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimmune Advance in Depressive Disorder.
    Zhao G; Liu X
    Adv Exp Med Biol; 2019; 1180():85-98. PubMed ID: 31784958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression.
    Raison CL; Lowry CA; Rook GA
    Arch Gen Psychiatry; 2010 Dec; 67(12):1211-24. PubMed ID: 21135322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational evidence for the Inflammatory Response System (IRS)/Compensatory Immune Response System (CIRS) and neuroprogression theory of major depression.
    Debnath M; Berk M; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110343. PubMed ID: 33961966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression.
    Zou W; Feng R; Yang Y
    PLoS One; 2018; 13(6):e0197267. PubMed ID: 29856741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the relationship between proinflammatory cytokines and major depressive disorder.
    Young JJ; Bruno D; Pomara N
    J Affect Disord; 2014 Dec; 169():15-20. PubMed ID: 25128861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cytokines in reduction of depressive symptoms: A comprehensive review.
    Shariq AS; Brietzke E; Rosenblat JD; Barendra V; Pan Z; McIntyre RS
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():86-91. PubMed ID: 29309829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of anti-inflammatory treatment interventions on depression in individuals with major depressive disorder and high levels of inflammation: A systematic review of randomized clinical trials.
    Allison DJ; Sharma B; Timmons BW
    Physiol Behav; 2019 Aug; 207():104-112. PubMed ID: 31078670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relation between depression and inflammation].
    Fisker L; Köhler-Forsberg O; Hageman I
    Ugeskr Laeger; 2018 May; 180(20):. PubMed ID: 29761778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory mechanisms in major depressive disorder.
    Raedler TJ
    Curr Opin Psychiatry; 2011 Nov; 24(6):519-25. PubMed ID: 21897249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is depression an inflammatory disorder?
    Raison CL; Miller AH
    Curr Psychiatry Rep; 2011 Dec; 13(6):467-75. PubMed ID: 21927805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research review: the role of cytokines in depression in adolescents: a systematic review.
    Mills NT; Scott JG; Wray NR; Cohen-Woods S; Baune BT
    J Child Psychol Psychiatry; 2013 Aug; 54(8):816-35. PubMed ID: 24027786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Depressive Subtypes within the Neuroinflammation Hypothesis of Major Depressive Disorder.
    Woelfer M; Kasties V; Kahlfuss S; Walter M
    Neuroscience; 2019 Apr; 403():93-110. PubMed ID: 29604382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classical Risk Factors and Inflammatory Biomarkers: One of the Missing Biological Links between Cardiovascular Disease and Major Depressive Disorder.
    Baghai TC; Varallo-Bedarida G; Born C; Häfner S; Schüle C; Eser D; Zill P; Manook A; Weigl J; Jooyandeh S; Nothdurfter C; von Schacky C; Bondy B; Rupprecht R
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Proinflammatory Cytokines in Dopaminergic System Disturbances, Implications for Anhedonic Features of MDD.
    Pan Z; Rosenblat JD; Swardfager W; McIntyre RS
    Curr Pharm Des; 2017; 23(14):2065-2072. PubMed ID: 28078987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokines, growth factors, and depression.
    Lotrich F
    Curr Pharm Des; 2012; 18(36):5920-35. PubMed ID: 22681170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine imbalance in the pathophysiology of major depressive disorder.
    Kim YK; Na KS; Shin KH; Jung HY; Choi SH; Kim JB
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1044-53. PubMed ID: 17433516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, serotonin and major depression.
    Catena-Dell'Osso M; Rotella F; Dell'Osso A; Fagiolini A; Marazziti D
    Curr Drug Targets; 2013 May; 14(5):571-7. PubMed ID: 23531160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for Inflammation-Associated Depression.
    Liu CS; Adibfar A; Herrmann N; Gallagher D; Lanctôt KL
    Curr Top Behav Neurosci; 2017; 31():3-30. PubMed ID: 27221622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of periodontitis in hospital outpatients with major depressive disorder. A focus on gingival and circulating cytokines.
    Solis ACO; Marques AH; Dominguez WV; Prado EBA; Pannuti CM; Lotufo RFM; Lotufo-Neto F
    Brain Behav Immun; 2016 Mar; 53():49-53. PubMed ID: 26616397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.